Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines

Chun Ming Tsai, Kuo Ting Chang, Li Hua Wu, Jeou Yuan Chen, Adi F. Gazdar, Tetsuya Mitsudomi, Mei Hui Chen, Reury Perng Perng

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Using a panel of 20 non-small cell lung cancer (NSCLC) cell lines established from previously untreated patients, we investigated the relationships between intrinsic chemoresistance (to four agents used commonly in the therapy of NSCLC) and HER-2/neu gene expression (which encodes glycoprotein p185(neu)), p53 gene mutations, and cell proliferation characteristics. Our results demonstrated that high p185(neu) expression was correlated with chemoresistance, low S-phase fractions, and long doubling times. By contrast, cell lines expressing relatively low levels of p185(neu) were relatively chemosensitive and had higher S-phase fractions and shorter doubling times. Although mutation of the p53 gene was a common event in this panel of cell lines (present in 18 of 20 lines), there was no relationship between mutations at any specific codon and chemoresistance or cell proliferation characteristics. Multivariate analysis revealed thai the level of pl85(neu) was the only independent predictor fur chemoresistance to doxorubicin, etoposide, and probably cisplatin. Although intrinsic chemoresistance almost certainly is a multifactorial process, overexpression of p185(neu) may be an important factor in the chemoresistance of NSCLC.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalCancer Research
Volume56
Issue number1
StatePublished - Jan 1 1996

Fingerprint

erbB-2 Genes
p53 Genes
Non-Small Cell Lung Carcinoma
Cell Proliferation
S Phase
Gene Expression
Cell Line
Mutation
Etoposide
Codon
Doxorubicin
Cisplatin
Glycoproteins
Multivariate Analysis
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines. / Tsai, Chun Ming; Chang, Kuo Ting; Wu, Li Hua; Chen, Jeou Yuan; Gazdar, Adi F.; Mitsudomi, Tetsuya; Chen, Mei Hui; Perng, Reury Perng.

In: Cancer Research, Vol. 56, No. 1, 01.01.1996, p. 206-209.

Research output: Contribution to journalArticle

Tsai, Chun Ming ; Chang, Kuo Ting ; Wu, Li Hua ; Chen, Jeou Yuan ; Gazdar, Adi F. ; Mitsudomi, Tetsuya ; Chen, Mei Hui ; Perng, Reury Perng. / Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines. In: Cancer Research. 1996 ; Vol. 56, No. 1. pp. 206-209.
@article{bf35ca8bbc8749588c4bdf46c323decb,
title = "Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines",
abstract = "Using a panel of 20 non-small cell lung cancer (NSCLC) cell lines established from previously untreated patients, we investigated the relationships between intrinsic chemoresistance (to four agents used commonly in the therapy of NSCLC) and HER-2/neu gene expression (which encodes glycoprotein p185(neu)), p53 gene mutations, and cell proliferation characteristics. Our results demonstrated that high p185(neu) expression was correlated with chemoresistance, low S-phase fractions, and long doubling times. By contrast, cell lines expressing relatively low levels of p185(neu) were relatively chemosensitive and had higher S-phase fractions and shorter doubling times. Although mutation of the p53 gene was a common event in this panel of cell lines (present in 18 of 20 lines), there was no relationship between mutations at any specific codon and chemoresistance or cell proliferation characteristics. Multivariate analysis revealed thai the level of pl85(neu) was the only independent predictor fur chemoresistance to doxorubicin, etoposide, and probably cisplatin. Although intrinsic chemoresistance almost certainly is a multifactorial process, overexpression of p185(neu) may be an important factor in the chemoresistance of NSCLC.",
author = "Tsai, {Chun Ming} and Chang, {Kuo Ting} and Wu, {Li Hua} and Chen, {Jeou Yuan} and Gazdar, {Adi F.} and Tetsuya Mitsudomi and Chen, {Mei Hui} and Perng, {Reury Perng}",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "56",
pages = "206--209",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines

AU - Tsai, Chun Ming

AU - Chang, Kuo Ting

AU - Wu, Li Hua

AU - Chen, Jeou Yuan

AU - Gazdar, Adi F.

AU - Mitsudomi, Tetsuya

AU - Chen, Mei Hui

AU - Perng, Reury Perng

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Using a panel of 20 non-small cell lung cancer (NSCLC) cell lines established from previously untreated patients, we investigated the relationships between intrinsic chemoresistance (to four agents used commonly in the therapy of NSCLC) and HER-2/neu gene expression (which encodes glycoprotein p185(neu)), p53 gene mutations, and cell proliferation characteristics. Our results demonstrated that high p185(neu) expression was correlated with chemoresistance, low S-phase fractions, and long doubling times. By contrast, cell lines expressing relatively low levels of p185(neu) were relatively chemosensitive and had higher S-phase fractions and shorter doubling times. Although mutation of the p53 gene was a common event in this panel of cell lines (present in 18 of 20 lines), there was no relationship between mutations at any specific codon and chemoresistance or cell proliferation characteristics. Multivariate analysis revealed thai the level of pl85(neu) was the only independent predictor fur chemoresistance to doxorubicin, etoposide, and probably cisplatin. Although intrinsic chemoresistance almost certainly is a multifactorial process, overexpression of p185(neu) may be an important factor in the chemoresistance of NSCLC.

AB - Using a panel of 20 non-small cell lung cancer (NSCLC) cell lines established from previously untreated patients, we investigated the relationships between intrinsic chemoresistance (to four agents used commonly in the therapy of NSCLC) and HER-2/neu gene expression (which encodes glycoprotein p185(neu)), p53 gene mutations, and cell proliferation characteristics. Our results demonstrated that high p185(neu) expression was correlated with chemoresistance, low S-phase fractions, and long doubling times. By contrast, cell lines expressing relatively low levels of p185(neu) were relatively chemosensitive and had higher S-phase fractions and shorter doubling times. Although mutation of the p53 gene was a common event in this panel of cell lines (present in 18 of 20 lines), there was no relationship between mutations at any specific codon and chemoresistance or cell proliferation characteristics. Multivariate analysis revealed thai the level of pl85(neu) was the only independent predictor fur chemoresistance to doxorubicin, etoposide, and probably cisplatin. Although intrinsic chemoresistance almost certainly is a multifactorial process, overexpression of p185(neu) may be an important factor in the chemoresistance of NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=0030031576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030031576&partnerID=8YFLogxK

M3 - Article

C2 - 8548764

AN - SCOPUS:0030031576

VL - 56

SP - 206

EP - 209

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -